India

32.7 lakh doses administered in India on June 10 : COVID-19 Vaccine Tracker

By Administrator_ India

Capital Sands

More than 32.74 lakh COVID-19 vaccine doses were administered in India on June 10, the Union Health Ministry’s latest provisional report suggested. With that, the cumulative number of COVID-19 vaccine doses administered in the country reached 24.60 crores.

On the 146th day of the vaccination drive (June 10), 29.54 lakh beneficiaries received their first shot and 3.20 lakh people were given their second dose.

The government has revised the gap between the two doses for the Oxford-AstraZeneca’s Covishield, being manufactured by the Serum Institute of India, to 12-16 weeks. However, the interval for the second dose of Bharat Biotech’s Covaxin remains unchanged.

Prime Minister Narendra Modi launched the nationwide vaccination drive on January 16, with healthcare workers at the frontline of India’s COVID-19 battle getting their first jabs. The country began the second phase of the vaccination drive from March 1 in which everyone above 60 years of age and those over 45 years with comorbidities could start getting the vaccine.

Here’s the vaccination count for some states:

STATES TOTAL BENEFICIARIES
Andhra Pradesh 1,14,80,538
Arunachal Pradesh 4,00,506
Assam 45,82,985
Bihar  1,15,92,170
Chandigarh  3,89,334
Chhattisgarh 71,79,201
Delhi 59,11,818
Goa 6,08,379
Gujarat  1,94,59,282
Haryana 65,49,595
Himachal Pradesh 25,66,114
Jharkhand  47,98,134
Karnataka  1,62,28,253
Kerala 1,09,69,126
Madhya Pradesh  1,37,60,927
Maharashtra 2,52,66,452
Odisha  87,99,028
Punjab 54,58,124
Rajasthan 1,88,22,045
Tamil Nadu 1,02,60,805
Telangana 73,86,484
Uttar Pradesh  2,19,99,548
Uttarakhand 32,06,521
West Bengal 1,71,30,501

Administrator_India

About Author

Leave a comment

Your email address will not be published. Required fields are marked *

You may also like

Indian bond yields surge as government borrowing balloons
India

Indian bond yields surge as government borrowing balloons

By Ritu, Capital Sands India’s benchmark 10-year bond yield surged on Monday following the government’s decision to sharply increase market
COVID19 India

India approves emergency use of remdesivir to treat COVID-19 patients

By Administrator_India Capital Sands India’s government said on Tuesday it has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency